Compounders sue FDA again over declaring end of shortage for Novo's semaglutide
25th February 2025 Uncategorised 0Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s weight loss drugs without a fight. The Outsourcing Facilities Association and a Texas-based compounder have filed a lawsuit against the FDA in U.S.
read more